KYIV, June 3 – The European Bank for Reconstruction and Development (EBRD) will provide a EUR25 million six-year loan to the Yuria-Pharm pharmaceutical group of companies for the launch of new production lines.

"The new production lines will improve access to affordable cancer and other socially significant treatment," the EBRD said in a statement.

In particular, the new lines will make it possible to produce drugs in smaller dosages, which will make treatment more affordable, the EBRD told Interfax-Ukraine.